Remove Collective Remove Extraction Remove Packaging Remove Pharmaceutical
article thumbnail

Flora Growth Completes Successful First Cannabis Extraction Through New Facility, Initiates EU-GMP Certification Process

Cannabis Law Report

Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction.

article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience. Join Us in Advancing Cannabis Science to Elevate the Industry , by Pelin Thorogood, Co-founder and Executive Chair of Radicle Science, and Nicole Brown, Chief Innovation Officer of Open Book Extracts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain

Cannabis Law Report

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. Warrant Exercise Update.

article thumbnail

Charlotte’s Web Has New COO

Cannabis Law Report

. (“Charlotte’s Web” or the “Company”), the world’s most trusted hemp extract and market leader in hemp-derived cannabidiol (“CBD”) wellness products , is pleased to announce that David Panter has joined the Company as Chief Operating Officer, effective March 30, 2020.

article thumbnail

MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership

Cannabis Law Report

Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:

article thumbnail

MediPharm Labs Announces Participation at Upcoming BMO & TMX Hemp & Medical Cannabis Conference in London, UK

Cannabis Law Report

TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference in London, UK on October 16, 2019.

Hemp 40
article thumbnail

MediPharm sues Hexo claiming breach for $9.8M in unpaid bills

Cannabis Law Report

after alleging the pot producer failed to pay for millions of dollars’ worth of cannabis oil over a supply deal signed last year, the marijuana extraction company said in a court filing. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian extraction facility.